The new facility increases the company's xanthine derivatives manufacturing capacity to 9,600 TPA, positioning Aarti Pharmalabs among the world's top three manufacturers in the segment
The collaboration aims to shorten early drug discovery timelines, improve the quality of lead candidates, and increase the likelihood of clinical success by enabling better decision-making
The launch of Rashfree Eva cream and spray extends the brand beyond baby care, offering targeted solutions for skin rashes, chafing, and diaper-related irritation in women and elderly adults
The company has completed its first commercial dispatch worth Rs. 50 crore and expects supplies of around Rs. 225 crore in the second quarter
NaMuscla is the only approved treatment for myotonia symptoms in NDM in Europe
Unveiled at the BIO International Convention 2026, the initiative brings together leaders from pharma, biotech, academia, government, investment, and patient advocacy
The Great Place to Work India recognition makes Aragen the first and only Indian CRDMO to feature among the country’s top list, highlighting its people-first workplace culture.
Voyageur has budgeted US$2,350,000 for completion of the Bayer project feasibility study and will create a final budget for the integrated iodine and barium drug facility feasibility study
The deal marks a strategic expansion for Jagsonpal into the hospital segment
This acquisition further strengthens our late-stage oncology pipeline
The launch comes amid a growing burden of neuropathy in India, driven by the rising prevalence of diabetes and nutritional deficiencies
Supported by the UK Government's Global AMR Innovation Fund, each selected innovation will receive funding of up to £170,000, along with incubation, mentoring, and technology support to accelerate commercialisation
With access to over 1,500 healthcare products and savings of up to 90%compared to conventional market prices, the platform aims to help consumers reduce their healthcare expenses
The proposed joint venture will accelerate the launch of pharmaceutical and consumer healthcare products across South-East Asia, the Middle East, Africa, and other emerging markets
The facility comes at a time when demand for women's healthcare solutions is rising globally, driven by increasing awareness and diagnosis of hormonal disorders, growing demand for fertility treatments
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
Carotid artery disease accounts for up to 30% of all strokes
The Foundation says it is working alongside NGOs, healthcare professionals, patient groups, and local communities to build programs
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
Subscribe To Our Newsletter & Stay Updated
